Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 4/20 | 0.50 |
| ▸ | TSHR | P16473 | 4/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.38 |
| ▸ | HPGD | P15428 | 3/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.38 |
| ▸ | LMNA | P02545 | 3/20 | 0.38 |
| ▸ | EGFR | P00533 | 2/20 | 0.38 |
| ▸ | CA2 | P00918 | 2/20 | 0.38 |
| ▸ | FYN | P06241 | 2/20 | 0.38 |
| ▸ | MMP9 | P14780 | 2/20 | 0.38 |
| ▸ | RECQL | P46063 | 2/20 | 0.38 |
| ▸ | MMP2 | P08253 | 2/20 | 0.38 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | MMP8 | P22894 | 1/20 | 0.38 |
| ▸ | CA6 | P23280 | 1/20 | 0.38 |
| ▸ | CDK2 | P24941 | 1/20 | 0.38 |
| ▸ | MMP12 | P39900 | 1/20 | 0.38 |
| ▸ | ADAMTS5 | Q9UNA0 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28179325 | 0.85 | TSHR (0.43) | ALOX15TSHRALDH1A1HPGDHSD17B10 | |
| SCHEMBL7201903 | 0.82 | ALOX15 (0.46) | ALOX15TSHRALDH1A1HPGDHSD17B10 | |
| SCHEMBL4551579 | 0.82 | ALDH1A1 (0.47) | ALOX15TSHRALDH1A1HPGDHSD17B10 | |
| SCHEMBL1033771 | 0.81 | ALOX15 (0.50) | ALOX15TSHRALDH1A1HPGDHSD17B10 | |
| SCHEMBL7640576 | 0.79 | TSHR (0.48) | ALOX15TSHRALDH1A1HPGDHSD17B10 | |
| SCHEMBL1425126 | 0.79 | ALOX15 (0.48) | ALOX15TSHRALDH1A1HPGDHSD17B10 | |
| SCHEMBL5341513 | 0.79 | ALOX15 (0.48) | ALOX15TSHRALDH1A1HPGDHSD17B10 | |
| SCHEMBL10890690 | 0.79 | TSHR (0.43) | ALOX15TSHRALDH1A1HPGDHSD17B10 | |
| Hydrochloric Acid SCHEMBL28211444 | 0.77 | TSHR (0.46) | ALOX15TSHRALDH1A1HPGDHSD17B10 | |
| SCHEMBL2123567 | 0.76 | CYP3A4 (0.42) | ALOX15TSHRALDH1A1HPGDHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2592083-A1 | FUSED QUINAZOLINE DERIVATIVES AND USES THEREOF | Shenzhen Salubris Pharmaceuticals Co., Ltd. (CN) | 2013-05-15 | — | — | EP | disclosed |
| US-20110288086-A1 | POLYCYCLIC QUINAZOLINES, PREPARATION THEREOF, AND USE THEREOF | SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. (CN) | 2011-11-24 | — | — | US | disclosed |
| EP-2352483-A1 | HAIR COLOURING METHOD COMPRISING AFTERTREATMENT | Henkel AG & Co. KGaA (DE) | 2011-08-10 | — | — | EP | disclosed |
| EP-2315576-A1 | CATIONIC ACETYLPYRIDINIUM DERIVATIVES FOR USE AS BLEACH ACTIVATORS | Henkel AG & Co. KGaA (DE) | 2011-05-04 | — | — | EP | disclosed |
| EP-2306967-A1 | COLORATION USING CATIONIZABLE POLYMER | Henkel AG & Co. KGaA (DE) | 2011-04-13 | — | — | EP | disclosed |
| US-20100280072-A1 | 2-'4-(HYDROXYMETHYL-PHENYLAMINO) -PIPERIDINE-1-YL!-N- (9H-CARBAZOL-3YL) - ACETAMINE DERIVATIVES AND RELATED COMPOUNDS AS NEUROPEPTIDE Y5 (NPY5) LIGANDS FOR THE TREATMENT OF OBESITY | LABORATORIOS DEL DR. ESTEVE S.A (ES) | 2010-11-04 | — | — | US | disclosed |
| US-20100280072-A1 | 2-'4-(HYDROXYMETHYL-PHENYLAMINO) -PIPERIDINE-1-YL!-N- (9H-CARBAZOL-3YL) - ACETAMINE DERIVATIVES AND RELATED COMPOUNDS AS NEUROPEPTIDE Y5 (NPY5) LIGANDS FOR THE TREATMENT OF OBESITY | LABORATORIOS DEL DR. ESTEVE S.A (ES) | 2010-11-04 | — | — | US | disclosed |
| US-20100280072-A1 | 2-'4-(HYDROXYMETHYL-PHENYLAMINO) -PIPERIDINE-1-YL!-N- (9H-CARBAZOL-3YL) - ACETAMINE DERIVATIVES AND RELATED COMPOUNDS AS NEUROPEPTIDE Y5 (NPY5) LIGANDS FOR THE TREATMENT OF OBESITY | LABORATORIOS DEL DR. ESTEVE S.A (ES) | 2010-11-04 | — | — | US | disclosed |
| WO-2010060730-A1 | HAIR COLOURING METHOD COMPRISING AFTERTREATMENT | HENKEL AG & CO. KGAA (DE) | 2010-06-03 | — | — | WO | disclosed |
| WO-2010022996-A1 | CATIONIC ACETYLPYRIDINIUM DERIVATIVES FOR USE AS BLEACH ACTIVATORS | HENKEL AG & CO. KGAA (DE) | 2010-03-04 | — | — | WO | disclosed |
| EP-1651220-B1 | 2-[4- (2-HYDROXYMETHYL-PHENYLAMINO)-PIPERIDIN-1-YL] - N-(9H-CARBAZOL-3-YL) - ACETAMIDE DERIVATIVES AND RELATED COMPOUNDS AS NEUROPEPTIDE Y5 (NPY5) LIGANDS FOR THE TREATMENT OF OBESITY | ESTEVE LABOR DR (ES) | 2006-12-20 | — | — | EP | disclosed |
| CN-1829516-A | S 2-'4(phenylamino)-piperidin-1-yl!-n-phenyl-acetamine derivatives and related compounds as neuropeptide y5 (npy5) ligands for the treatement of obesity | ESTEVE LABOR DR (ES) | 2006-09-06 | — | — | CN | disclosed |
| WO-2006087019-A1 | AGENTS FOR COLOURING KERATIN CONTAINING FIBRES | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2006-08-24 | — | — | WO | disclosed |
| EP-1651220-A1 | 2-[4- (2-HYDROXYMETHYL-PHENYLAMINO)-PIPERIDIN-1-YL] - N-(9H-CARBAZOL-3-YL) - ACETAMIDE DERIVATIVES AND RELATED COMPOUNDS AS NEUROPEPTIDE Y5 (NPY5) LIGANDS FOR THE TREATMENT OF OBESITY | LABORATORIOS DEL DR. ESTEVE, S.A. (ES) | 2006-05-03 | — | — | EP | disclosed |
| WO-2006029686-A1 | METHOD FOR STYLISHLY CHANGING THE COLOR OF KERATINIC FIBERS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2006-03-23 | — | — | WO | disclosed |
| CN-1196464-C | Novel couplers for oxidative hair dyeing | P & G CLAROR INC (US) | 2005-04-13 | — | — | CN | disclosed |
| WO-2005013990-A1 | 2-`4-(HYDROXYMETHYL-PHENYLAMINO) -PIPERIDINE-1-YL!-N- (9H-CARBAZOL-3-YL) - ACETAMINE DERIVATIVES AND RELATED COMPOUNDS AS NEUROPEPTIDE Y5 (NPY5) LIGANDS FOR THE TREATMENT OF OBESITY | LABORATORIOS DEL DR. ESTEVE S.A. (ES) | 2005-02-17 | — | — | WO | disclosed |
| CN-1551756-A | Composition for dyeing keratinous fibres comprising a particular dicationic diazo dye | �ź㴫 | 2004-12-01 | — | — | CN | disclosed |
| CN-1396819-A | Novel couplers for oxidative hair dyeing | P & G CLAROR INC (US) | 2003-02-12 | — | — | CN | disclosed |
| CN-1334718-A | Hair treatment method | NOVOZYMES AS (DK) | 2002-02-06 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110288086-A1 | POLYCYCLIC QUINAZOLINES, PREPARATION THEREOF, AND USE THEREOF | AURKA, AURKC, AURKB | ALOX15 4805/4885TSHR 4426/4885ALDH1A1 3950/4885 |
| US-20100280072-A1 | 2-'4-(HYDROXYMETHYL-PHENYLAMINO) -PIPERIDINE-1-YL!-N- (9H-CARBAZOL-3YL) - ACETAMINE DERIVATIVES AND RELATED COMPOUNDS AS NEUROPEPTIDE Y5 (NPY5) LIGANDS FOR THE TREATMENT OF OBESITY | NPY5R, NPY4R, NPY2R | ALOX15 573/4885TSHR 438/4885ALDH1A1 948/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.